home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Eliminate the Confusion - New Requirements for Clinical Laboratories to Meet GCP

 
  March 29, 2011  
     
 


ComplianceOnline, Online Event
2011-04-14


This webinar on Good Clinical Practices will help clinical laboratories, analyzing samples from clinical trials, understand the compliance requirements concerning ICH GCP for FDA and EMA compliance.
 

Why Should You Attend:

As a result of the FDA and EU Clinical Trials Directive 200/20/EC and subsequent promulgation of laws, EMA inspection and reflection paper in clinical laboratories in the EU covering the conduct of clinical trials in accordance with Good Clinical Practice (GCP), there is the need for laboratories undertaking analysis of samples from clinical trials to comply with GCP regulations and guidance. The standard to be followed by such laboratories is not well defined in FDA and ICH GCP and hence the development of new EMA standards which provides guidance on the standards anticipated which will set the gold standard in the EU and US.

In particular Article 15 of EU Clinical Trials Directive 2001/20/EC provides provision for the inspection of laboratories that perform the analysis or evaluation of samples collected as part of a clinical trial and so companies must ensure the laboratories they use are in compliance with good clinical practice.

The presentation will review the key requirement for compliance for the analysis of samples collected from subjects participating in clinical trials and forms a key part of the clinical trials process. Sample analysis or evaluation provides important data on a range of endpoints which is used, for example, to assess the pharmacokinetic profile of investigational medicinal products and to monitor their safety and efficacy. Consequently, it is essential that sample analysis and evaluation is performed to an acceptable standard which will ensure patient safety is not compromised and that data is reliable and accurately reported.

This presentation will explain the new standards which will be required by laboratories analyzing clinical trial samples. The session is aimed at sponsors using clinical laboratories and those at laboratories who wish to demonstrate to sponsors of clinical trials and government agencies worldwide that the clinical laboratory operates to a standard that assures the reliability, quality and integrity of the work and results generated.

Areas Covered in the Seminar:

  • What does GCP and the new guidance require of clinical laboratories?
  • What parts of GCP apply to clinical laboratories?
  • What standards should the laboratory be working to?
  • How to assess a clinical laboratory? Sponsor companies should assess the laboratory before placement to ensure that all aspects of GCP are satisfactorily addressed and that the laboratory standards and methods meet GCP requirements.
  • Facilities, to assess the orderliness, cleanliness and environmental suitability of premises where study specific activities are to be carried out and the arrangements for storage of materials and samples.
  • Procedures for sample collection, receipt and application of acceptance/rejection criteria and for the preparation of reagents.
  • What documentation should be available – including SOPs, validation, technical agreements?
  • What is required to ensure quality and appropriateness of methodology in use in any laboratory?
  • What should be included in the contract between the laboratory and the sponsor?
  • What is the role of the sponsor company during the study?
  • What should be included in the final reports of the analysis?
Who Will Benefit:

This webinar will provide critical assistance to FDA and EMA regulated companies currently carrying out or preparing to conduct clinical trials for pharmaceutical, biotechnology, and biologics products using clinical laboratories. It will also be applicable to personnel working in clinical laboratories.

  • Clinical Development managers and personnel
  • Clinical research associates
  • Clinical Research archiving and document management personnel
  • Quality assurance managers and auditors
  • Clinical Development managers and personnel
  • Consultants
  • Laboratories analyzing samples from clinical trials
  • Operations / Production Managers
  • Quality Assurance Managers
  • SOP mangers and co-ordinators
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount. 
 
 
 
Organized by: ComplianceOnline
Invited Speakers:

Dr Laura Brown, PhD, MBA, Diploma Clinical Sciencesis an independent QA and Training Consultant in the Pharmaceutical Industry, and Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. Laura has more than 17 year’s experience of running clinical trials and clinical quality assurance in the pharmaceutical industry.

Laura Brown has held a number of international and senior management QA positions in the pharmaceutical industry including as an Associate Director with a leading GCP audit consultancy. She has worked for several international companies including GlaxoWellcome, Hoechst Marion Roussel and Phoenix International.

Laura is author of a chapter on “Training QA staff” in the leading GXP book: “Good Clinical, Laboratory and Manufacturing Practices” (2007). She is author of SCRIP’s latest GCP guide and a “Practical Guide to the Clinical Trial Directive. She is also co-author of several books including “Developing the Individual” and “Project Management for the Pharmaceutical Industry”. She has regularly lectured at conferences and on training courses on QA and GCP issues.

 
Deadline for Abstracts: 2011-04-14
 
Registration:

Attend Live Online Training

$349.00 One Dial In 

$499.00 Get Training CD Only

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.